𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

✍ Scribed by Nicolino Ruperto; Daniel J. Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pérez; Clovis A. Silva; Carlos Abud-Mendoza; Ruben Burgos-Vargas; Valeria Gerloni; Jose A. Melo-Gomes; Claudia Saad-Magalhães; J. Chavez-Corrales; Christian Huemer; Alan Kivitz; Francisco J. Blanco; Ivan Foeldvari; Michael Hofer; Gerd Horneff; Hans-Iko Huppertz; Chantal Job-Deslandre; Anna Loy; Kirsten Minden; Marilynn Punaro; Alejandro Flores Nunez; Leonard H. Sigal; Alan J. Block; Marleen Nys; Alberto Martini; Edward H. Giannini


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
128 KB
Volume
62
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Long-term safety and efficacy of etanerc
✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye

Safety and efficacy of meningococcal c v
✍ Evelien Zonneveld-Huijssoon; Arash Ronaghy; Marion A. J. Van Rossum; Ger T. Rijk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract ## Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. ## Methods In this multicent

A randomized, double-blind clinical tria
✍ Nicolino Ruperto; Irina Nikishina; Evgueni D. Pachanov; Ynessa Shachbazian; Anne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## Objective In an international, multicenter, double‐blind, randomized clinical trial we evaluated the short‐term (3 months) and long‐term (12 months) efficacy and safety of 2 different doses of meloxicam oral suspension compared with the efficacy and safety of naproxen oral suspensio